301 related articles for article (PubMed ID: 23206870)
1. End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.
Tang W; Mohandas J; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
BMC Nephrol; 2012 Dec; 13():164. PubMed ID: 23206870
[TBL] [Abstract][Full Text] [Related]
2. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
[TBL] [Abstract][Full Text] [Related]
4. End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases.
Mallett A; Tang W; Hart G; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Clayton PA; Johnson DW
Am J Nephrol; 2015; 42(3):177-84. PubMed ID: 26418732
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
Yang WL; Bose B; Zhang L; Mcstea M; Cho Y; Fahim M; Hawley CM; Pascoe EM; Johnson DW
PLoS One; 2019; 14(8):e0221531. PubMed ID: 31442267
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
[TBL] [Abstract][Full Text] [Related]
7. End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.
Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; de Zoysa JR; Johnson DW
Nephrol Dial Transplant; 2013 Feb; 28(2):455-61. PubMed ID: 23182810
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
9. End-stage kidney disease due to scleroderma--outcomes in 127 consecutive ANZDATA registry cases.
Siva B; McDonald SP; Hawley CM; Rosman JB; Brown FG; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
Nephrol Dial Transplant; 2011 Oct; 26(10):3165-71. PubMed ID: 21357212
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
Zhang L; Lee G; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Kidney Int; 2016 Jun; 89(6):1337-45. PubMed ID: 27165824
[TBL] [Abstract][Full Text] [Related]
11. Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study.
See EJ; Johnson DW; Hawley CM; Pascoe EM; Badve SV; Boudville N; Clayton PA; Sud K; Polkinghorne KR; Borlace M; Cho Y
Am J Kidney Dis; 2018 Aug; 72(2):188-197. PubMed ID: 29277508
[TBL] [Abstract][Full Text] [Related]
12. The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.
Tang W; Bose B; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; Peh CA; Johnson DW
Clin J Am Soc Nephrol; 2013 May; 8(5):773-80. PubMed ID: 23349331
[TBL] [Abstract][Full Text] [Related]
13. Changing survival of people with myeloma and end stage kidney disease: A cohort study using Australian and New Zealand dialysis and transplant registry 1963-2013.
Webster AC; Irish AB; Kelly PJ
Nephrology (Carlton); 2018 Mar; 23(3):217-225. PubMed ID: 28004444
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
Hruskova Z; Pippias M; Stel VS; Abad-Díez JM; Benítez Sánchez M; Caskey FJ; Collart F; De Meester J; Finne P; Heaf JG; Magaz A; Palsson R; Reisæter AV; Salama AD; Segelmark M; Traynor JP; Massy ZA; Jager KJ; Tesar V
Am J Kidney Dis; 2019 Feb; 73(2):184-193. PubMed ID: 30122544
[TBL] [Abstract][Full Text] [Related]
15. Absolute risk and risk factors for stroke mortality in patients with end-stage kidney disease (ESKD): population-based cohort study using data linkage.
De La Mata NL; Alfaro-Ramirez M; Kelly PJ; Masson P; Al-Shahi Salman R; Webster AC
BMJ Open; 2019 Feb; 9(2):e026263. PubMed ID: 30798318
[TBL] [Abstract][Full Text] [Related]
16. Survival With Dialysis Versus Kidney Transplantation in Adult Hemolytic Uremic Syndrome Patients: A Fifteen-Year Study of the Waiting List.
Santos AH; Casey MJ; Wen X; Zendejas I; Rehman S; Womer KL; Andreoni KA
Transplantation; 2015 Dec; 99(12):2608-16. PubMed ID: 26050014
[TBL] [Abstract][Full Text] [Related]
17. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.
Disney AP
Am J Kidney Dis; 1995 Jan; 25(1):165-75. PubMed ID: 7810521
[TBL] [Abstract][Full Text] [Related]
18. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.
Le Clech A; Simon-Tillaux N; Provôt F; Delmas Y; Vieira-Martins P; Limou S; Halimi JM; Le Quintrec M; Lebourg L; Grangé S; Karras A; Ribes D; Jourde-Chiche N; Rondeau E; Frémeaux-Bacchi V; Fakhouri F
Kidney Int; 2019 Jun; 95(6):1443-1452. PubMed ID: 30982675
[TBL] [Abstract][Full Text] [Related]
19. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
Koye DN; Magliano DJ; Reid CM; Pavkov ME; Chadban SJ; McDonald SP; Polkinghorne KR; White S; Paul C; Shaw JE
Am J Kidney Dis; 2019 Mar; 73(3):300-308. PubMed ID: 30579709
[TBL] [Abstract][Full Text] [Related]
20. Haemodialysis withdrawal in Australia and New Zealand: a binational registry study.
Chan S; Marshall MR; Ellis RJ; Ranganathan D; Hawley CM; Johnson DW; Wolley MJ
Nephrol Dial Transplant; 2020 Apr; 35(4):669-676. PubMed ID: 31397483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
